SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending following recent community discussion about the company's financial momentum, including the retirement of convertible notes and expectations for continued revenue growth from its core portfolio. Investors are also closely monitoring the upcoming XP-8121 Phase 3 trial, which remains a primary focus as a key long-term catalyst for the company.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, and Defense. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce is trending as investors anticipate upcoming half-year earnings and potential announcements regarding a major hyperscaler contract for data center power solutions. The conversation remains bullish, supported by strong sector demand for aero-engines and nuclear power, despite minor volatility from broader market movements.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is trending amid ongoing debate over its long-term potential as an institutional financial infrastructure project versus claims that it is a pump-and-dump scheme. While some traders point to the potential acquisition of Chains technology and development of the Onyx Neobank as bullish catalysts, others express frustration over stagnant price action and poor communication.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is facing downward pressure following the launch of a new $1 billion at-the-market equity offering program, fueling intense debate among traders regarding persistent dilution and insider stock sales. While some market participants remain bullish on the long-term potential for nuclear power in AI data center infrastructure, others express skepticism, citing the company's lack of commercial revenue and its historical stock price decline.

Netskope, Inc. engages in the provision of cloud-based security solutions. It offers business developing analytics for visibility, policy enforcement and other cloud solutions. Its products include Netskope one Secure Access Services Edge (SASE), Netskope one Security Service Edge (SSE), cloud access security broker, next generation secure web gateway, private access, cloud firewall, Software-Defined Wide Area Network (SD-WAN), and skopeAI. The company was founded by Sanjay Beri, Lebin Cheng, Ravishankar Ithal and Krishna Narayanaswamy in October 2012 and is headquartered in Santa Clara, CA.

Netskope Inc. - Ordinary Shares - Class A

Netskope is experiencing downward pressure and increased volatility following the announcement of new AI security features by Anthropic, which triggered sector-wide concerns regarding potential disruption to established cybersecurity firms. While traders remain divided on the long-term impact of AI on the company's competitive position, some investors are highlighting the stock's recent price decline as an attractive entry point for a long-term position, pointing to strong product demand and its status as a potential acquisition target.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is receiving attention as traders monitor its recent v5.0 mainnet upgrade, which introduced post-quantum security features, and discuss its potential as a long-term hold. Sentiment remains polarized, with bulls pointing to the network's technological capabilities and institutional adoption, while skeptics emphasize the project's long-term price decline and ongoing token dilution.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

The S&P 500 is trending as traders analyze a mix of economic data, including CPI and PPI prints, alongside ongoing concerns about Federal Reserve rate hike risks and Middle East geopolitical tensions. Discussion remains fragmented, with some investors reacting to these macro catalysts while others debate the sustainability of market valuations amid AI-related sentiment.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending as traders speculate on a potential buyout and await upcoming Phase 3 clinical data. The community remains highly focused on the company's IgA nephropathy asset, frequently citing high institutional ownership and significant short interest as catalysts for a potential short squeeze.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is experiencing a significant stock price decline, with traders debating whether the selling pressure is driven by institutional manipulation, recent insider selling, or a correction following a speculative pre-earnings rally. While some investors view the current price as an attractive entry point for a long-term turnaround, others are concerned about the stock's continued downward momentum and lack of immediate catalysts.

Boost Run, Inc. is a provider of scalable cloud infrastructure purpose-built for enterprise AI and high-performance computing workloads. The platform delivers GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. The company was founded on September 5, 2025 and is headquartered in Northbrook, IL.

Boost Run Inc. - Ordinary Shares - Class A

Boost Run Inc.

Boost Run Inc. is trending as traders react to positive second-quarter earnings, which included significant revenue growth and the announcement of a new long-term infrastructure lease with 10X Capital. While many investors are expressing bullish sentiment regarding the company's contracted backlog and its status as an Nvidia Exemplar cloud partner, some discussion is tempered by concerns over share dilution related to warrant redemptions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


fereshtegannn

fereshtegan shop